NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
BIO 2007 — Annual Conference
The 2007 BIO International Convention drew record attendance with representatives from 64 countries. BIO Brings The world to boston 2007 BIO International Convention Surpasses Records The BIO International convention, produced by the Biotechnology Industry Organization (BIO), drew a record 22,366 attendees, an almost 15% increase from the previous year, with representatives from 48 states and 64 countries. One-third of attendees came from outside the United States. The BIO Exhibition featured the largest gathering of biotech exhibitors in history, with more than 1,900 companies, and 60 domestic, country, and regional pavilions representing every aspect of the biotechnology industry. “The 2007 BIO International Convention was a phenomenal success,” says BIO President and CEO Jim Greenwood. “With almost 30% of our attendees coming from outside the United States and pavilions from 39 countries or geographic regions, it truly was the global event for biotechnology.” Event highlights included keynote addresses from Michael J. Fox, founder of the Michael J. Fox Foundation for Parkinson’s Research, and Her Majesty Queen Noor of Jordan. Mr. Fox, who appeared before a packed room, urged the biotechnology industry to continue to innovate and accelerate the translation of basic science into improved therapies for patients. Queen Noor discussed the opportunities presented by biotech to address global health and poverty issues. The full convention program included four full days with more than 200 breakout sessions covering 20 educational tracks on the most pressing issues in biotechnology, including global health, biofuels, stem-cell research, vaccines, investment strategies, white biotechnology, and dozens more. The BIO Business Forum also set records for attendance and partnering meetings. More than 6,000 attendees representing 1,503 companies participated in the Forum and held 12,103 partnering meetings. PharmaVOICE welcomes comments about this article. E-mail us at email@example.com. Aerovance Thought Leader: William J. Newell Executive VP Episode: Biologics Development Alfacell Corp. Thought Leader: Lawrence A. Kenyon Chief Financial Officer Episode: Development Partnerships Avalon Pharmaceuticals Thought Leader: Kenneth C. Carter, Ph.D. President and CEO Episode: Emerging Biotechnology BioAdvance Thought Leader: Barbara Schilberg, CEO, Biotechnology Greenhouse of SE Pennsylvania Episode: Seed Funding Cambridge Healthcare & Biotech Ltd. Thought Leader: Martyn Postle Chairman and Chief Executive Episode: Global Biotech Trends DEBIOPHARM S.A. Thought Leader: Lucienne Cicurel, Ph.D. Secretary General Episode: Competition in the Oncology Space EntreMed Inc. Thought Leader: James S. Burns President and CEO Episode: Multimechanism Drugs Kansas Biotech Thought Leader: Pat Roberts, U.S. Senator Episode: State Biotechnology Initiatives Nastech Pharmaceutical Co. Thought Leader: Timothy Duffy Executive VP, Marketing and Business Development Episode: Macromolecule Opportunities P&G Pharmaceuticals Inc. Thought Leaders: Jeff Davis, Head, Global New Business Development Kevin Driscoll, Ph.D. Director, New Technology Development Episode: New R&D Business Model S*BIO Pte Ltd. Thought Leader: Stephen Keith Rhind, Ph.D. Senior VP Episode: Integrated Development Strategies Trial Acceleration Institute Thought Leader: Scott Ballenger, R.Ph. President Episode: Hot Trends and Initiatives PharmaVOICE would like to thank the following thought leaders for participating in our live Podcast episodes, which cover a multitude of topics, during the recent BIO convention. Podcast Episodes: Industry Thought Leaders Create a BIO Buzz Dr. Stephen Keith Rhind heads the corporate development activities at S*BIO. Martyn Postle presented the findings from Cambridge Healthcare & Biotech Ltd.’s review of its UK Drug Pipeline survey at BIO 2007. EntreMed’s James Burns leads the life-sciences company’s strategic direction. The 2007 BIO International Convention The 2007 BIO International Convention is the world’s largest event for the biotechnology industry. The Convention ran Sunday, May 6, through Wednesday, May 9, at the Boston Convention and Exhibition Center. 1. The Boston Exhibition & Convention Center played host to the annual gathering of biotech thought leaders. 2. A record number of attendees — 22,366 in total — had the opportunity to visit the exhibit hall. 3. Row after row after row of exhibitors showcased their services, products, and offerings. 4. The annual BIO Conference, May 6-9, in Boston, was the center of the BIO world. 5. Event highlights included a keynote address from Michael J. Fox, founder of the Michael J. Fox Foundation for Parkinson’s Research. 6. Pavilions from 39 countries or geographic regions, supported attendees representing a total of 64 countries. 7. Boston provided an ideal backdrop as one of the leading global biotech hubs. 8. Forty-eight states in the union were represented at the annual conference, with many fielding pavilions to showcase their unique capabilities. 9. More than 6,000 attendees representing 1,503 companies participated in the BIO Business Forum and held 12,103 partnering meetings.10. The BIO Exhibition featured the largest gathering of biotech exhibitors in history, with more than 1,900 companies, and 60 domestic, country, and regional pavilions representing every aspect of the biotechnology industry.